HRT Financial’s BriaCell Therapeutics Corp Warrant BCTXZ Stock Holding History

HRT Financial’s Portfolio BCTXZ Stock Details BCTXZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$32K	Buy	164,379 +96,444	+142%	+$11.9K	﹤0.01%	4418
2026 Q2	$6K	Buy	+67,935	New	+$6.61K	﹤0.01%	4025

Other funds holding BCTXZ

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

HRT Financial's BCTXZ Position: Q3 2026 in Review

HRT Financial increased its BriaCell Therapeutics Corp Warrant (BCTXZ) stake by 142% in Q3 2026, buying an estimated $11.9K and bringing the position to 164,379 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #4418.

HRT Financial first reported a position in BCTXZ in Q2 2026 and has held it in 2 quarters since. 2 funds tracked by Wall St. Rank hold BCTXZ as of Q3 2026.

HRT Financial held 164,379 shares of BriaCell Therapeutics Corp Warrant worth $32K as of Q3 2026.
HRT Financial bought 96,444 BriaCell Therapeutics Corp Warrant shares in Q3 2026, an estimated $11.9K.
BriaCell Therapeutics Corp Warrant made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #4418 holding.
HRT Financial first reported a position in BriaCell Therapeutics Corp Warrant in Q2 2026 and has held it in 2 quarters since.
2 funds tracked by Wall St. Rank held BriaCell Therapeutics Corp Warrant as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.